{ETtoday News Agency, 21st exclusive} Libbond Pharma-B (09637) is currently up 6.7%, trading at HK$18, with approximately 60,000 shares traded, involving a turnover of HK$1.03 million.
Libbond Pharma-B (09637) announced that it will from time to time repurchase its H-shares in the open market, with the total amount not exceeding RMB 100 million. The proposed share repurchase will be funded by the company's own financial resources, excluding proceeds raised from the global offering.
The group stated that the repurchased H-shares will be cancelled or held as treasury shares in such manner as the board of directors considers appropriate. The share repurchase is intended to safeguard the value of the group and the interests of shareholders. The group's existing financial resources allow it to maintain a sound financial position while repurchasing shares. (am)
Libbond Pharma-B (09637) announced that it will from time to time repurchase its H-shares in the open market, with the total amount not exceeding RMB 100 million. The proposed share repurchase will be funded by the company's own financial resources, excluding proceeds raised from the global offering.
The group stated that the repurchased H-shares will be cancelled or held as treasury shares in such manner as the board of directors considers appropriate. The share repurchase is intended to safeguard the value of the group and the interests of shareholders. The group's existing financial resources allow it to maintain a sound financial position while repurchasing shares. (am)
